Clinical Trials Directory

Trials / Unknown

UnknownNCT04606225

Losartan Effects on Emotion-memory Interaction

The Role of the Renin-angiotensin System in Emotion-memory Interactions

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
University of Electronic Science and Technology of China · Academic / Other
Sex
Male
Age
18 Years – 30 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to investigate whether a single dose of losartan (50 mg) can affect emotion-memory interaction in healthy humans and its underlying neural mechanisms.

Detailed description

Animal models and initial findings in humans suggest a role of the renin-angiotensin system in cognitive and emotional processes. Accumulating evidence demonstrates modulatory effects of the angiotensin antagonist losartan in the domains of memory and emotional processing. Against this background the present study aims to investigate the behavioral and neural effects of a single dose of losartan on emotional processing and emotion-memory integration in healthy subjects. In a double-blind, between-subject, placebo-controlled pharmaco-fMRI experiment, 60 male participants will be randomized to a single dose of losartan (50 mg) or placebo, and encode emotional pictures during fMRI (scheduled 90 minutes after drug administration). Then 24 hours post fMRI participants will finish a surprise recognition memory test to estimate the emotion effects on subsequent memory.

Conditions

Interventions

TypeNameDescription
DRUGLosartanadministration of losartan (50 mg) (oral) Cozaar Oral Tablet
DRUGPlacebo Oral Tabletadministration of placebo (oral)

Timeline

Start date
2020-10-10
Primary completion
2021-12-31
Completion
2022-03-31
First posted
2020-10-28
Last updated
2020-10-28

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04606225. Inclusion in this directory is not an endorsement.